Project Grant R34DA063037
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$764K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Rhode Island, USA
Similar Awards
This $1,192,612 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to integrate HIV prevention services into clinical care settings for people with opioid use disorder (OUD). The key objectives are to: 1) conduct a systematic assessment of healthcare utilization, HIV prevention services, and medication for OUD (MOUD) using claims and emergency department data; 2) use an evidence-based quality improvement...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to design tailored harm reduction strategies to address the escalating drug overdose crisis in the United States. The $2,316,128 award, with a project period from September 15, 2024 to July 31, 2028, will support collaborative efforts with health departments and community partners across six jurisdictions (Rhode Island, Massachusetts, New York...
This federal Project Grant award of $677,250 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and testing of the Healthcare Empowerment and Advocacy for Recovery from Trafficking (HEART) intervention. The HEART intervention aims to engage women with experiences of sex trafficking or who are vulnerable to sex trafficking into comprehensive care services, including for HIV, substance use disorders (SUDs),...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,729,018 to the University of Rhode Island (URI) to develop and evaluate a mobile health intervention for individuals with co-morbid opioid use disorder (OUD) and post-traumatic stress disorder (PTSD) during community re-entry. The key products and services to be delivered include: 1) a rigorously developed mobile app with on-demand PTSD-OUD...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $711,000 to Kaiser Foundation Hospitals to develop and assess the feasibility and efficacy of a mobile health (mHealth) intervention for young adult women affected by sex trafficking. The goal is to adapt an existing mHealth intervention to reduce substance use and HIV risk behaviors among this population. The project will utilize...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) is aimed at implementing a low-threshold Hepatitis C (HCV) treatment strategy in a jail setting. The $252,042 award, effective September 15, 2024, will support a pilot study at Rhode Island Hospital to evaluate the feasibility and effectiveness of the "MINMON-J" approach, which modifies a minimal monitoring HCV treatment protocol for use...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will pilot an innovative digital Contingency Management (CM) treatment delivered via mobile device to Medicaid beneficiaries with co-occurring opioid and alcohol use disorders. The $390,000 award, spanning from September 2024 to August 2027, aims to: 1) identify optimal approaches to engage Medicaid beneficiaries in digital CM through Medicaid claims data...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), is intended to develop and pilot a telehealth intervention delivered through syringe service programs (SSPs) to improve uptake and retention of pre-exposure prophylaxis (PrEP) and medications for opioid use disorder (MOUD) among racially and regionally diverse people who inject drugs (PWID) in Minnesota. The $239,148 award, with a project period...
This Project Grant award, valued at $2,362,500 and effective from July 1, 2025 to June 30, 2029, was provided by the National Institute on Drug Abuse (NIDA) under the federal Drug Use and Addiction Research Programs (CFDA 93.279). The project aims to overcome policy and regulatory barriers that hinder access to evidence-based harm reduction and treatment services for preventing HIV transmission and overdose among people who use drugs. Key deliverables include: 1) a tool to identify policy...
The National Institute on Drug Abuse (NIDA) awarded a $267,696 Project Grant under CFDA 93.279 - Drug Use and Addiction Research Programs to the University of Massachusetts Lowell (UML), a minority-serving institution, for the project "Enhancing Opportunities for Addiction Research in the Merrimack Valley." The project aims to expand UML's existing Public Health Informatics and Technology (PHIT) program by creating a new PHIT-AR (Addiction Research) track. This will recruit diverse...